Effect of a GnRH Analog on Hepatic Steatosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of a GnRH Analog on Hepatic Steatosis — Stella

Home/Metabolic Dysfunction-Associated Steatotic Liver Disease/

View on ClinicalTrials.gov

Recruiting

Back to Metabolic Dysfunction-Associated Steatotic Liver Disease trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

Greece

1st Department of Obstetrics and Gynecology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki

424 General Military Hospital, Thessaloniki

Key details

Phase

Post-approval study

Sponsor

Aristotle University Of Thessaloniki

Collaborators

424 General Military Hospital

Enrollment target

~62 participants

Started

November 2024

Primary completion

April 2027

Age range

18 Years – 45 Years

Sex

Female only

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.